HEALTHY EXTRACTS INC. (HYEX) Financial Statements (2026 and earlier)
Company Profile
| Business Address |
7375 COMMERCIAL WAY HENDERSON, NV 89011 |
| State of Incorp. | NV |
| Fiscal Year End | December 31 |
| Industry (SIC) | 2833 - Medicinal Chemicals and Botanical Products (benchmarking) |
| More info | Complete Financial Analysis Financial Benchmarking |
Balance Sheet (Statement of Financial Position) ($ in thousands)
| 9/30/2025 MRQ | 12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | |||
|---|---|---|---|---|---|---|---|---|---|
| ASSETS | |||||||||
| Current Assets | |||||||||
| Cash, cash equivalents, and short-term investments | 112 | 19 | 66 | 222 | 59 | 133 | |||
| Cash and cash equivalent | 112 | 19 | 66 | 222 | 59 | 133 | |||
| Receivables | 11 | 30 | 106 | 133 | 13 | 26 | |||
| Inventory, net of allowances, customer advances and progress billings | 1,361 | 1,626 | 1,819 | 1,958 | 2,418 | 3,081 | |||
| Inventory | 1,361 | 1,626 | 1,819 | 1,958 | 2,418 | 3,081 | |||
| Deferred costs | 149 | 152 | |||||||
| Other undisclosed current assets | 26 | 72 | (0) | 0 | |||||
| Total current assets: | 1,659 | 1,900 | 1,991 | 2,313 | 2,490 | 3,241 | |||
| Noncurrent Assets | |||||||||
| Long-term investments and receivables | |||||||||
| Long-term investments | |||||||||
| Intangible asset, including goodwill, after accumulated amortization | 197 | 197 | 199 | 194 | 199 | 208 | |||
| Goodwill | 193 | 193 | 193 | 193 | 193 | 193 | |||
| Intangible asset, excluding goodwill, after accumulated amortization | 3 | 3 | 6 | 1 | 6 | 15 | |||
| Prepaid expense | 53 | ||||||||
| Deposits noncurrent assets | |||||||||
| Other undisclosed noncurrent assets | 522 | 539 | 539 | 522 | 426 | ||||
| Total noncurrent assets: | 719 | 735 | 791 | 716 | 625 | 208 | |||
| TOTAL ASSETS: | 2,378 | 2,635 | 2,781 | 3,030 | 3,115 | 3,450 | |||
| LIABILITIES AND EQUITY | |||||||||
| Liabilities | |||||||||
| Current Liabilities | |||||||||
| Accounts payable and accrued liabilities | 301 | 332 | 186 | 110 | 76 | 124 | |||
| Interest and dividends payable | ✕ | ✕ | ✕ | ✕ | 13 | 2 | 50 | ||
| Accounts payable | 52 | 117 | 91 | 37 | 65 | 21 | |||
| Accrued liabilities | 249 | 215 | 95 | 59 | 9 | 53 | |||
| Debt | 2 | 361 | 275 | 172 | 7 | 80 | |||
| Due to related parties | ✕ | ✕ | ✕ | 171 | 171 | 1,051 | |||
| Other undisclosed current liabilities | 1,664 | 987 | 442 | 107 | 8 | 3,060 | |||
| Total current liabilities: | 1,968 | 1,680 | 903 | 559 | 262 | 4,315 | |||
| Noncurrent Liabilities | |||||||||
| Liabilities, other than long-term debt | |||||||||
| Operating lease, liability | |||||||||
| Other undisclosed noncurrent liabilities | |||||||||
| Total noncurrent liabilities: | |||||||||
| Other undisclosed liabilities | |||||||||
| Total liabilities: | 1,968 | 1,680 | 903 | 559 | 262 | 4,315 | |||
| Equity | |||||||||
| Equity, attributable to parent, including: | 410 | 955 | 1,878 | 2,471 | 2,854 | (866) | |||
| Common stock | 355 | 354 | 345 | 338 | 309 | 122 | |||
| Treasury stock, value | (5) | ||||||||
| Additional paid in capital | 19,302 | 19,000 | 17,460 | 17,076 | 15,501 | 9,543 | |||
| Accumulated deficit | (19,240) | (18,400) | (15,927) | (14,944) | (12,956) | (10,530) | |||
| Other undisclosed equity, attributable to parent | 0 | 0 | 0 | ||||||
| Other undisclosed equity | |||||||||
| Total equity: | 410 | 955 | 1,878 | 2,471 | 2,854 | (866) | |||
| TOTAL LIABILITIES AND EQUITY: | 2,378 | 2,635 | 2,781 | 3,030 | 3,115 | 3,450 | |||
Income Statement (P&L) ($ in thousands)
| 9/30/2025 TTM | 12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | ||
|---|---|---|---|---|---|---|---|---|
| Revenues | 3,113 | 2,486 | 2,251 | 1,677 | 1,277 | 748 | ||
| Sales-type lease, revenue | 3,113 | 2,486 | 2,251 | |||||
| Other operating income | (98) | (523) | 1,573 | |||||
| Cost of revenue | (1,202) | (864) | (880) | (771) | (1,855) | (524) | ||
| Cost of product and service sold | (1,202) | (864) | (783) | (346) | (1,892) | |||
| Other undisclosed gross profit | (0) | (0) | (211) | (0) | ||||
| Gross profit: | 1,911 | 1,622 | 1,372 | 695 | (578) | 224 | ||
| Operating expenses | (2,094) | (3,866) | (2,283) | (2,584) | (1,475) | (1,164) | ||
| Operating loss: | (183) | (2,244) | (912) | (1,889) | (2,053) | (940) | ||
| Nonoperating expense (Other Nonoperating expense) | (658) | (229) | (72) | |||||
| Interest and debt expense | 38 | 38 | 47 | 53 | ||||
| Loss from continuing operations before income taxes: | (802) | (2,435) | (983) | (1,889) | (2,006) | (887) | ||
| Other undisclosed income (loss) from continuing operations | (87) | 1,520 | ||||||
| Income (loss) from continuing operations: | (802) | (2,435) | (983) | (1,976) | (2,006) | 633 | ||
| Income (loss) before gain (loss) on sale of properties: | ✕ | ✕ | ✕ | ✕ | (1,976) | (2,006) | 633 | |
| Other undisclosed net loss | (38) | (38) | (11) | (570) | ||||
| Net income (loss) available to common stockholders, diluted: | (841) | (2,473) | (983) | (1,987) | (2,576) | 633 | ||
Comprehensive Income ($ in thousands)
| 9/30/2025 TTM | 12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | ||
|---|---|---|---|---|---|---|---|---|
| Net income (loss): | (841) | (2,473) | (983) | (1,987) | (2,576) | 633 | ||
| Comprehensive income (loss), net of tax, attributable to parent: | (841) | (2,473) | (983) | (1,987) | (2,576) | 633 | ||
Statements Sources
The financial statements are based on the Company's filings with the U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.